Patent ID: 9511115
Filing Date: 2016-12-06
CPC Classification: A61K,A61L,A61P,G01N,Y10T

Claim Text:
1. A pharmaceutical composition for treating, preventing, or ameliorating a bone related condition in a mammal, comprising an effective amount of a NELL peptide and a carrier or scaffold that includes BMP2 and hyaluronan, wherein the effective amount is effective for a bone related condition selected from the group consisting of osteoporosis, bone loss due to microgravity, disuse atrophy, prolonged bed-rest, and a disease that involves multiple symptoms where bone metabolism is a secondary effect or is selected from the group consisting of atopic soft tissue calcification, gall stone, kidney stones, pineal gland calcification, cataracts, salivary stones, cardiac valves, and prostate stones.